학술논문

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
Document Type
Article
Author
Munro, A.P.S.Babbage, G.Cathie, K.Owens, D.R.Pacurar, M.Saich, S.Read, R.C.Faust, S.N.Feng, S.Aley, P.K.Kanji, N.Minassian, A.M.Lambe, T.Snape, M.D.Liu, X.Janani, L.Cornelius, V.Mujadidi, Y.F.Baxter, D.Mughal, M.Bula, M.Dodd, K.Chatterjee, K.Enever, Y.Qureshi, E.Green, C.A.Goodman, A.L.Bawa, T.Harndahl, L.Haughney, J.Thomson, E.C.Hicks, A.van der Klaauw, A.A.Libri, V.Rampling, T.Llewelyn, M.J.Sharma, S.McGregor, A.C.Maallah, M.Moore, P.Holliday, K.Twelves, C.Osanlou, O.Osanlou, R.Palfreeman, A.Pan, D.Regan, K.Saralaya, D.Sheridan, R.Todd, S.Charlton, S.Hallis, B.Ramsay, M.Andrews, N.Nguyen-Van-Tam, J.S.Riordan, A.Ustianowski, A.Rogers, C.Katechia, K.Cooper, A.Freedman, A.Hughes, R.Grundy, L.Tudor Jones, L.Harrison, E.Snashall, E.Mallon, L.Burton, K.Storton, K.Munusamy, M.Tandy, B.Egbo, A.Cox, S.Ahmed, N.N.Shenoy, A.Bousfield, R.Wixted, D.Gutteridge, H.Mansfield, B.Herbert, C.Murira, J.Calderwood, J.Barker, D.Brandon, J.Tulloch, H.Colquhoun, S.Thorp, H.Radford, H.Evans, J.Baker, H.Thorpe, J.Batham, S.Hailstone, J.Phillips, R.Kumar, D.Westwell, F.Sturdy, A.Barcella, L.Soussi, N.Mpelembue, M.Raj, S.Sharma, R.Corrah, T.John, L.Whittington, A.Roche, S.Wagstaff, L.Farrier, A.Bisnauthsing, K.Abeywickrama, M.Spence, N.Packham, A.Serafimova, T.Aslam, S.McGreevy, C.Borca, A.DeLosSantosDominguez, P.Palmer, E.Broadhead, S.Farooqi, S.Piper, J.Weighell, R.Pickup, L.Shamtally, D.Domingo, J.Kourampa, E.Hale, C.Gibney, J.Stackpoole, M.Rashid-Gardner, Z.Lyon, R.McDonnell, C.Cole, C.Stewart, A.McMillan, G.Savage, M.Beckett, H.Moorbey, C.Desai, A.Brown, C.Naker, K.Gokani, K.Trinham, C.Sabine, C.Moore, S.Hurdover, S.Justice, E.Stone, M.Plested, E.Ferreira Da Silva, C.White, R.Robinson, H.Turnbull, I.Morshead, G.Drake-Brockman, R.Smith, C.Li, G.Kasanyinga, M.Clutterbuck, E.A.Bibi, S.Singh, M.Champaneri, T.Irwin, M.Khan, M.Kownacka, A.Nabunjo, M.Osuji, C.Hladkiwskyj, J.Galvin, D.Patel, G.Grierson, J.Males, S.Askoolam, K.Barry, J.Mouland, J.Longhurst, B.Moon, M.Giddins, B.Pereira Dias Alves, C.Richmond, L.Minnis, C.Baryschpolec, S.Elliott, S.Fox, L.Graham, V.Baker, N.Godwin, K.Buttigieg, K.Knight, C.Brown, P.Lall, P.Shaik, I.Chiplin, E.Brunt, E.Leung, S.Allen, L.Thomas, S.Fraser, S.Choi, B.Gouriet, J.Perkins, J.Gowland, A.Macdonald, J.Seenan, J.P.Starinskij, I.Seaton, A.Peters, E.Singh, S.Gardside, B.Bonnaud, A.Davies, C.Gordon, E.Keenan, S.Hall, J.Wilkins, S.Tasker, S.James, R.Seath, I.Littlewood, K.Newman, J.Boubriak, I.Suggitt, D.Haydock, H.Bennett, S.Woodyatt, W.Hughes, K.Bell, J.Coughlan, T.van Welsenes, D.Kamal, M.Cooper, C.Tunstall, S.Ronan, N.Cutts, R.Dare, T.Yim, Y.T.N.Whittley, S.Hamal, S.Ricamara, M.Adams, K.Baker, H.Driver, K.Turner, N.Rawlins, T.Roy, S.Merida-Morillas, M.Sakagami, Y.Andrews, A.Goncalvescordeiro, L.Stokes, M.Ambihapathy, W.Spencer, J.Parungao, N.Berry, L.Cullinane, J.Presland, L.Ross Russell, A.Warren, S.Baker, J.Oliver, A.Buadi, A.Lee, K.Haskell, L.Romani, R.Bentley, I.Whitbred, T.Fowler, S.Gavin, J.Magee, A.Watson, T.Nightingale, K.Marius, P.Summerton, E.Locke, E.Honey, T.Lingwood, A.de la Haye, A.Elliott, R.S.Underwood, K.King, M.Davies-Dear, S.Horsfall, E.Chalwin, O.Burton, H.Edwards, C.J.Welham, B.Appleby, K.Dineen, E.Garrahy, S.Hall, F.Ladikou, E.Mullan, D.Hansen, D.Campbell, M.Dos Santos, F.Lakeman, N.Branney, D.Vamplew, L.Hogan, A.Frankham, J.Wiselka, M.Vail, D.Wenn, V.Renals, V.Ellis, K.Lewis-Taylor, J.Habash-Bailey, H.Magan, J.Hardy, A.
Source
In: The Lancet Infectious Diseases. (The Lancet Infectious Diseases, August 2022, 22(8):1131-1141)
Subject
Language
English
ISSN
14744457
14733099